These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 14566202)

  • 21. Extended-release formulation of venlafaxine in the treatment of post-traumatic stress disorder.
    Pae CU; Lim HK; Ajwani N; Lee C; Patkar AA
    Expert Rev Neurother; 2007 Jun; 7(6):603-15. PubMed ID: 17563244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical application of paroxetine for tapering benzodiazepine use in non-major-depressive outpatients visiting an internal medicine clinic.
    Nakao M; Takeuchi T; Nomura K; Teramoto T; Yano E
    Psychiatry Clin Neurosci; 2006 Oct; 60(5):605-10. PubMed ID: 16958945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paroxetine: a new serotonin reuptake inhibitor for the treatment of depression.
    Sherman TL; McDougle CJ; Price LH
    Conn Med; 1993 Sep; 57(9):587-92. PubMed ID: 8252846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.
    Kamijima K; Aoki M
    Expert Rev Neurother; 2006 Jul; 6(7):945-56. PubMed ID: 16831110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duloxetine in the treatment of generalized anxiety disorder.
    Kornstein SG; Russell JM; Spann ME; Crits-Christoph P; Ball SG
    Expert Rev Neurother; 2009 Feb; 9(2):155-65. PubMed ID: 19210191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose paroxetine treatment for an adolescent with obsessive-compulsive disorder comorbid with Asperger's disorder.
    Sasayama D; Sugiyama N; Imai J; Hayashida A; Harada Y; Amano N
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):251. PubMed ID: 19335398
    [No Abstract]   [Full Text] [Related]  

  • 28. Treating generalized anxiety disorder.
    Gorman JM
    J Clin Psychiatry; 2003; 64 Suppl 2():24-9. PubMed ID: 12625796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generalized anxiety disorder in primary care: emerging issues in management and treatment.
    Culpepper L
    J Clin Psychiatry; 2002; 63 Suppl 8():35-42. PubMed ID: 12044106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paroxetine treatment of major depressive disorder.
    Keller MB
    Psychopharmacol Bull; 2003; 37 Suppl 1():42-52. PubMed ID: 14566200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of generalized anxiety disorder.
    Gorman JM
    J Clin Psychiatry; 2002; 63 Suppl 8():17-23. PubMed ID: 12044104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical effect and tolerance of paxil (paroxetine) in management of panic disorders].
    Mosolov SN; Smulevich AB; Nuller IuL; Grigor'evskikh VS; Kostiukova EG; Kuzavkova MV; Koliutskaia EV; Andriushchenko AV; Zelenina EV; Kosinskiĭ VP; Kozlovskiĭ VL; Bykov SI; Pererva IG
    Ter Arkh; 2000; 72(10):16-23. PubMed ID: 11220870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacotherapy of generalized anxiety disorder: state of the art].
    Zullino DF; Hättenschwiler J; Mattia M; Stankovic M; Khazaal Y; Borgeat F
    Praxis (Bern 1994); 2003 Oct; 92(42):1775-9. PubMed ID: 14598534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of tianeptine or paroxetine on 35% CO2 provoked panic in panic disorder.
    Schruers K; Griez E
    J Psychopharmacol; 2004 Dec; 18(4):553-8. PubMed ID: 15582922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remission of generalized anxiety disorder: a review of the paroxetine clinical trials database.
    Rickels K; Rynn M; Iyengar M; Duff D
    J Clin Psychiatry; 2006 Jan; 67(1):41-7. PubMed ID: 16426087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paroxetine: a review.
    Bourin M; Chue P; Guillon Y
    CNS Drug Rev; 2001; 7(1):25-47. PubMed ID: 11420571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonergic drugs in the treatment of depressive and anxiety disorders.
    Den Boer JA; Bosker FJ; Slaap BR
    Hum Psychopharmacol; 2000 Jul; 15(5):315-336. PubMed ID: 12404310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. WCA recommendations for the long-term treatment of generalized anxiety disorder.
    Allgulander C; Bandelow B; Hollander E; Montgomery SA; Nutt DJ; Okasha A; Pollack MH; Stein DJ; Swinson RP;
    CNS Spectr; 2003 Aug; 8(8 Suppl 1):53-61. PubMed ID: 14767398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review.
    Bourin M
    Hum Psychopharmacol; 2003 Apr; 18(3):185-90. PubMed ID: 12672169
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.